1. Ackerson K. Interactive model of client health behavior and cervical cancer screening of African-American women. Public Health Nurs. 2011 May-Jun;28(3):271-80. PubMed | Google Scholar

  2. Adjorlolo-Johnson G, Unger ER, Boni-Ouattara E, Touré-Coulibaly K, Maurice C, Vernon SD, Sissoko M, Greenberg AE, Wiktor SZ, Chorba TL. Assessing the relationship between HIV infection and cervical cancer in Cote d'Ivoire: a case-control study. BMC Infect Dis. 2010 Aug 17;10:242. PubMed | Google Scholar

  3. Nji AN. Perceptions of Cameroonian Women Regarding Cervical Cancer Prevention. 2016. Google Scholar

  4. Allen JD, de Jesus M, Mars D, Tom L, Cloutier L, Shelton RC. Decision-making about the HPV vaccine among ethnically diverse parents: implications for health communications. J Oncol. 2012;2012:401979. PubMed | Google Scholar

  5. Ali SF, Ayub S, Manzoor NF, Azim S, Afif M, Akhtar N, Jafery WA, Tahir I, Farid-ul-Hasnian S, Uddin N. Knowledge and awareness about cervical cancer and its prevention amongst interns and nursing staff in Tertiary Care Hospitals in Karachi, Pakistan. PloS one. 2010 Jun 10;5(6): e11059. PubMed | Google Scholar

  6. Aragones A, Bruno D, Gany F. Attitudes surrounding implementation of the HPV vaccine for males among primary care providers serving large minority populations. J Health Care Poor Underserved. 2013 May;24(2):768-76. PubMed | Google Scholar

  7. Atashili J, Smith JS, Adimora AA, Eron J, Miller WC, Myers E. Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in sub-Saharan Africa: a simulation. PLoS One. 2011 Apr 4;6(4):e18527. PubMed | Google Scholar

  8. Atashili J, Miller WC, Smith JS, Ndumbe PM, Ikomey GM, Eron J, Rinas AC, Myers E, Adimora AA. Age trends in the prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Cameroon: a cross-sectional study. BMC research notes. 2012 Dec;5(1):590. PubMed | Google Scholar

  9. Trim K, Nagji N, Elit L, Roy K. Parental knowledge, attitudes, and behaviours towards human papillomavirus vaccination for their children: a systematic review from 2001 to 2011. Obstet Gynecol Int. 2012;2012:921236. PubMed | Google Scholar

  10. Enow Orack GE, Ndom P, Doh AS. Cancer Incidence in Cameroon. Yaoundé Cancer registry. Programme for Appropriate Technology in Health. Planning Appropriate. 2008.

  11. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low-and middle-income developing countries. Bull World Health Organ. 2001;79(10):954-62. Epub 2001 Nov 1. PubMed | Google Scholar

  12. Sankaranarayanan R, Black RJ, Swaminathan R, Parkin DM. An overview of cancer survival in developing countries. IARC scientific publications. 1998 Jan 1; 135-57. PubMed | Google Scholar

  13. Denny L. An evaluation of alternative strategies for the prevention of cervical cancer in low-resource settings (Doctoral dissertation, University of Cape Town). 2000. Google Scholar

  14. Mqoqi N, Kellet P, Madhoo J, Sitas F. Incidence of histologically diagnosed cancer in South Africa, 1996-1997. 2003.

  15. Bailie RS, Selvey CE, Bourne D, Bradshaw D. Trends in cervical cancer mortality in South Africa. Int J Epidemiol. 1996 Jun;25(3):488-93. PubMed | Google Scholar

  16. Gordon GMC. Carcinoma of the Cervix: A crying need for extensive screening. Hospital. 9; 36-40. Cited in Fonn et al (2003). Centre for Health Policy. 2001.

  17. Kjaer SK, Van den Brule AJ, Paull G, Svare EI, Sherman ME, Thomsen BL, Suntum M, Bock JE, Poll PA, Meijer CJ. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ. 2002 Sep 14;325(7364):572. PubMed | Google Scholar

  18. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002 Nov 21;347(21):1645-51. PubMed | Google Scholar

  19. Tebeu PM, Petignat P, Mhawech-Fauceglia P. Gynecological malignancies in Maroua, Cameroon. International Journal of Gynecology & Obstetrics. 2009 Feb 1;104(2):148-9. PubMed | Google Scholar

  20. Jemal A, Ward E, Thun M. Declining death rates reflect progress against cancer. PLoS One. 2010 Mar 9;5(3):e9584. PubMed | Google Scholar

  21. Kouam AD. The management of pre-invasive cervical lesions using cryotherapy in Yaounde, Cameroon. J Obstet Gynaecol. 1999 Nov;19(6):640-2. PubMed | Google Scholar

  22. Soudre B, Lamien TO, Sanou M, Sankande BL. Cervical premalignant lesions of the uterine cervix in Burkina; cytologic study in two Provinces (Oudalan, Seno). Med Afr Noire. 2002; 39:806-900.

  23. Solve B, Lamien TO, Kone B, M Sanou, Sankande BL. The precancerous cervical cancer of the uterine cervix uterine collar in Burkina, to study cytological actual Alisa in two provinces (Oudalan SÃ © no). Med Af N. 1992.

  24. WHO Cancer screening Cervical Uterine © rus. In: WHO editor. The fight against cancer of the cervix Uterine © rus. Guide to essential practice. 2016; p. 83-133. PubMed | Google Scholar

  25. Robyr R, Nazeer S, Vassilakos P, Matute JC, Sando Z, Halle G, Mbakop A, Campana A. Feasibility of cytology-based cervical cancer screening in rural Cameroon. Acta Cytol. 2002 Nov-Dec;46(6):1110-6. PubMed | Google Scholar

  26. Tebeu PM, Nkele N, Fokoua S, Sandjong DI, Achu P. Prevalence of precancerous lesions of the uterine cervix in Cameroon In Bali (North West). Cameroon Journal of Medicine. 2002;11:32.